Physician profile
Cody Williams
NPI 1750728010
$36,458.50
in general payments reported to CMS, 2019-2025
26 companies · $1,764 in 2025
The $1,764 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,767 · 2020: $27K · 2021: $1,229 · 2022: $139 · 2023: $633 · 2024: $419 · 2025: $1,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Travel and Lodging: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.46 |
| Travel and Lodging | $1,193.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $17,749.18 | 2019-2020 | |
| Abbott Laboratories | $14,890.46 | 2019-2023 | Aveir, Jot Dx |
| Biotronik INC. | $1,295.89 | 2025 | Selectra, Solia |
| Boston Scientific Corporation | $326.62 | 2020-2025 | Emblem Mri S-Icd |
| Biosense Webster, INC. | $318.42 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $284.37 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.50 | 2023-2024 | Lifevest |
| Medtronic, INC. | $232.46 | 2021-2025 | Micra, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $152.92 | 2021-2023 | Camzyos |
| Irhythm Technologies, INC. | $144.48 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astellas Pharma US INC | $113.67 | 2021 | |
| Philips North America LLC | $112.41 | 2023-2025 | Lm Undivided, (Am5) Lead Management |
| Siemens Medical Solutions USA, INC. | $96.49 | 2025 | Artis Icono Biplane |
| Pfizer INC. | $68.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $58.86 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $50.43 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.62 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $40.82 | 2020-2022 | |
| Convatec INC. | $32.22 | 2022 | |
| Kestra Medical Technology Services, INC. | $31.22 | 2022-2024 | Assure Wcd |
| Atricure, INC. | $31.10 | 2023 | |
| Impulse Dynamics (USA) INC. | $30.15 | 2021 | |
| Amgen INC. | $28.56 | 2021-2023 | Repatha |
| Cardiofocus, INC. | $22.48 | 2021 | |
| Ge Healthcare | $16.18 | 2023 | |
| Cardiva Medical, INC. | $14.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.